Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-08

Clinical Trial Update: Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair [NA]

View source ↗

Summary

A completed clinical trial comparing rapidly absorbing polyglactin 910 versus poliglecaprone 25 for laceration repair, with listed conditions including dyspareu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Poliglecaprone 25 (poliglecaprone 25)
  • Rapidly absorbing polyglactin 910 (polyglactin 910)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Dyspareunia, Perineal Tear | NA | Status: COMPLETED | Results posted: 2018-08-08